Literature DB >> 1356459

Fosfomycin/metronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective colorectal surgery. A randomised double-blind multicentre trial in 517 patients.

L Andåker1, L G Burman, A Eklund, H Graffner, J Hansson, R Hellberg, H Höjer, U Ljungqvist, K Kjellgren, P A Kling.   

Abstract

OBJECTIVE: To find out if fosfomycin together with metronidazole was any better than doxycycline with metronidazole for the prophylaxis of infection before elective colorectal operations.
DESIGN: Multicentre, double blind, random control trial.
SETTING: Nine Swedish hospitals. SUBJECTS-559 patients admitted for elective colorectal operations.
INTERVENTIONS: Fosfomycin 8 g and metronidazole 1 g before operation and fosfomycin 8 g eight hours afterwards, or doxycycline 400 mg and metronidazole 1 g before operation, and placebo eight hours afterwards. MAIN OUTCOME MEASURES: Incidence of all types of infection, mortality, and side effects.
RESULTS: There were no significant differences between the groups for any of the outcome measures studied, the overall abdominal infection rates (wound, deep, and septicaemia) being 4.6% and 7.4%, and the remote infection rates (pneumonia, urinary tract, and central venous line) 15.1% and 12.8%, respectively. Of the predictors studied, only duration of operation was significantly related to risk of infection.
CONCLUSION: The combination of fosfomycin and metronidazole was as safe and effective as that of doxycycline and metronidazole in preventing infections after elective colorectal operations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356459

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  6 in total

Review 1.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

Review 2.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

Review 3.  Operative and nonoperative therapy of intraabdominal infections.

Authors:  D H Wittmann
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

4.  Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database.

Authors:  Dmitri Iarikov; Ronald Wassel; John Farley; Sumathi Nambiar
Journal:  Infect Dis Ther       Date:  2015-10-05

5.  Shorter Total Length of Stay After Intraperitoneal Fosfomycin, Metronidazole, and Molgramostim for Complicated Appendicitis: A Pivotal Quasi-Randomized Controlled Trial.

Authors:  Siv Fonnes; Søren Roepstorff; Barbara Juliane Holzknecht; Christoffer Skov Olesen; Joachim Hjalde Halmsted Olsen; Line Schmidt; Rasmus Alder; Sara Gamborg; Tilde Rasmussen; Magnus Arpi; Lars Nannestad Jørgensen; Jacob Rosenberg
Journal:  Front Surg       Date:  2020-05-05

Review 6.  Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada.

Authors:  George G Zhanel; Michael A Zhanel; James A Karlowsky
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-06-25       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.